Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
How to explain the 'watch-and-wait' period to a CLL patient?
Allogeneic transplant for older AML patients - who, when and how
A short discussion of the unmet needs of CLL patients
How is the landscape of Hodgkin lymphoma therapy changing?